What does Dr. Van Steenkiste F., Neurologie do?

Dr. Van Steenkiste F., Neurologie is a specialist medical practice in Gent. Private Limited, started on 13 February 2020, 1 establishment.

What is the address of Dr. Van Steenkiste F., Neurologie?

The registered office of Dr. Van Steenkiste F., Neurologie is located at Venusschoentjestraat 4, 9041 Gent.

Is Dr. Van Steenkiste F., Neurologie still active?

Yes. According to the CBE (31 October 2026) Dr. Van Steenkiste F., Neurologie is active, legal situation “Normale toestand”, started on 13 February 2020.

Is Dr. Van Steenkiste F., Neurologie registered on Peppol?

Yes, Dr. Van Steenkiste F., Neurologie is registered on the Peppol network with ID 0208:0743650104.

What is the enterprise number of Dr. Van Steenkiste F., Neurologie?

The enterprise number of Dr. Van Steenkiste F., Neurologie is BE0743650104.

When was Dr. Van Steenkiste F., Neurologie founded?

Dr. Van Steenkiste F., Neurologie was founded on 13 February 2020.

Who are the directors of Dr. Van Steenkiste F., Neurologie?

According to the 2025 annual accounts, the directors of Dr. Van Steenkiste F., Neurologie are: Frank Van Steenkiste.

Is Dr. Van Steenkiste F., Neurologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 February 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Van Steenkiste F., Neurologie make in 2025?

Dr. Van Steenkiste F., Neurologie recorded a loss after taxes of € 65,489 in financial year 2025.

What is the revenue of Dr. Van Steenkiste F., Neurologie?

As a small company, Dr. Van Steenkiste F., Neurologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -48,607.

Dr. Van Steenkiste F., Neurologie (Private Limited)

Dossier Dr. Van Steenkiste F., Neurologie, printed on 31 October 2026 from databakkes.be/en/0743650104/dr-van-steenkiste-f-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Van Steenkiste F., Neurologie from Gent, company number BE0743650104, closed financial year 2025 with a result of € -65,489 after tax. For that financial year Dr. Van Steenkiste F., Neurologie recorded a gross margin of € -48,607 and equity of € 61,041. Compared with financial year 2024, the result moved from € 18,347 to € -65,489. The company made a loss. The buffer shrank hard: equity is 63 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Shrank hard

€ 61,041

▼ 63% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -65,489

▼ still € 18,347 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 23,013

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 61,040.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 46,708

▲ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,219

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,200

▼ 39% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 178,026 Gross margin 2022: € 178,026 First fiscal year in the series	€ 109,784 Gross margin 2023: € 109,784 ▼ 38% vs 2022 (€ 178,026) Unfavourable step	€ 38,132 Gross margin 2024: € 38,132 ▼ 65% vs 2023 (€ 109,784) Unfavourable step	€ -48,607 Gross margin 2025: € -48,607 ▼ € 86,739 vs 2024 (€ 38,132) Unfavourable step	▼ € 86,739
Profit after taxes	€ 132,640 Profit after taxes 2022: € 132,640 First fiscal year in the series	€ 71,768 Profit after taxes 2023: € 71,768 ▼ 46% vs 2022 (€ 132,640) Unfavourable step	€ 18,347 Profit after taxes 2024: € 18,347 ▼ 74% vs 2023 (€ 71,768) Unfavourable step	€ -65,489 Profit after taxes 2025: € -65,489 ▼ € 83,836 vs 2024 (€ 18,347) Unfavourable step	▼ € 83,836
Equity	€ 286,416 Equity 2022: € 286,416 First fiscal year in the series	€ 148,183 Equity 2023: € 148,183 ▼ 48% vs 2022 (€ 286,416) Unfavourable step	€ 166,530 Equity 2024: € 166,530 ▲ 12% vs 2023 (€ 148,183) Favourable step	€ 61,041 Equity 2025: € 61,041 ▼ 63% vs 2024 (€ 166,530) Unfavourable step	▼ 63%
Total debts	€ 95,154 Total debts 2022: € 95,154 First fiscal year in the series	€ 188,187 Total debts 2023: € 188,187 ▲ 98% vs 2022 (€ 95,154) Unfavourable step	€ 60,866 Total debts 2024: € 60,866 ▼ 68% vs 2023 (€ 188,187) Favourable step	€ 74,457 Total debts 2025: € 74,457 ▲ 22% vs 2024 (€ 60,866) Unfavourable step	▲ 22%
Cash	€ 174,989 Cash 2022: € 174,989 First fiscal year in the series	€ 129,838 Cash 2023: € 129,838 ▼ 26% vs 2022 (€ 174,989) Unfavourable step	€ 65,139 Cash 2024: € 65,139 ▼ 50% vs 2023 (€ 129,838) Unfavourable step	€ 23,013 Cash 2025: € 23,013 ▼ 65% vs 2024 (€ 65,139) Unfavourable step	▼ 65%
Retained profit	€ 286,415 Retained profit 2022: € 286,415 First fiscal year in the series	€ 148,182 Retained profit 2023: € 148,182 ▼ 48% vs 2022 (€ 286,415) Unfavourable step	€ 166,529 Retained profit 2024: € 166,529 ▲ 12% vs 2023 (€ 148,182) Favourable step	€ 61,040 Retained profit 2025: € 61,040 ▼ 63% vs 2024 (€ 166,529) Unfavourable step	▼ 63%
Dividend	€ 140,000 Dividend 2022: € 140,000 First fiscal year in the series	€ 210,000 Dividend 2023: € 210,000 ▲ 50% vs 2022 (€ 140,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 210,000) Unchanged	€ 40,000 Dividend 2025: € 40,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 381,570 Balance sheet total 2022: € 381,570 First fiscal year in the series	€ 336,370 Balance sheet total 2023: € 336,370 ▼ 12% vs 2022 (€ 381,570) Unchanged	€ 227,397 Balance sheet total 2024: € 227,397 ▼ 32% vs 2023 (€ 336,370) Unchanged	€ 135,498 Balance sheet total 2025: € 135,498 ▼ 40% vs 2024 (€ 227,397) Unchanged	▼ 40%

Key figures of Dr. Van Steenkiste F., Neurologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van Steenkiste F., Neurologie?

What happened at Dr. Van Steenkiste F., Neurologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: loss of € 65,489 (▼ € 83,836 vs 2024). Source: NBB ↗
Feb 13, 2020 New establishment in Gent. KBO
Feb 13, 2020 Start of the company according to the CBE. KBO
2020 Frank Van Steenkiste became a director. NBB

In short

From € 132,640 profit in 2022 to € 65,489 loss in 2025.

Paid € 69,238 in corporate taxes since 2022.

Best year ever: 2022, with € 132,640 profit.

Paid out € 390,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frank Van Steenkiste

Dr. Van Steenkiste F., Neurologie

Le Petit Paradis Des Lauzes

Behind Dr. Van Steenkiste F., Neurologie is Frank Van Steenkiste. Frank Van Steenkiste is also behind Le Petit Paradis Des Lauzes.

Directors

According to the 2025 annual accounts

Frank Van Steenkiste

Director

Also active at: Le Petit Paradis Des Lauzes

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Venusschoentjestraat 4

9041 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Dr. ADP, Neurologie

€ 240,819 gross margin · 2025

Le Petit Paradis Des Lauzes same network

€ -10,501 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0743.650.104
VAT number: BE 0743.650.104
Registered office: Venusschoentjestraat 4, 9041 Gent
Names & denominations: Dr. Van Steenkiste F., Neurologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 February 2020
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗